LataMed AI Explores Integration with Cashea to Offer Installment-Based Payments for Healthcare in Venezuela

LataMed AI Corp. is evaluating a partnership with buy-now-pay-later platform Cashea to reduce upfront financial barriers for patients in Venezuela, potentially boosting healthcare access and platform adoption.

June 11, 2026
LataMed AI Explores Integration with Cashea to Offer Installment-Based Payments for Healthcare in Venezuela

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that it has initiated an evaluation to integrate installment-based healthcare payment capabilities through Cashea, one of Venezuela's leading buy-now-pay-later financial technology platforms. The proposed initiative aims to reduce upfront financial barriers for patients seeking access to private healthcare services, consultations, diagnostics, wellness programs, and other eligible offerings within the LataMed AI ecosystem.

The company believes that improving payment accessibility could drive greater patient engagement, increased healthcare utilization, stronger platform adoption, and broader access to private healthcare services. By addressing affordability challenges, LataMed AI aims to strengthen its position as a technology-enabled healthcare marketplace serving patients, providers, and healthcare partners throughout Latin America.

Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while simultaneously expanding the reach and utility of our healthcare ecosystem. We believe initiatives such as this have the potential to strengthen patient acquisition, improve engagement, and support long-term platform growth.”

The potential integration aligns with LataMed AI’s broader strategy of combining artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility to create a more scalable healthcare marketplace. The company expects that a successful Cashea-related payment integration could support this vision, offering patients more flexible payment options while expanding the platform's utility.

However, LataMed AI emphasized that no definitive commercial agreement has been entered into as of the date of this release. Completion of any integration remains subject to further commercial discussions, technical implementation requirements, regulatory review, and customary business conditions. The company intends to provide additional updates as material developments occur.

This move comes as healthcare costs continue to be a significant barrier in emerging markets, particularly in Venezuela where economic challenges have limited access to private healthcare. By partnering with a local fintech leader like Cashea, LataMed AI could tap into a growing trend of buy-now-pay-later services expanding beyond retail into essential sectors like healthcare. If successful, this initiative could serve as a model for other markets in Latin America, potentially transforming how patients finance medical care.

For additional information, visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.